News

Our program provides superior clinical immunology and rheumatology training in a collaborative environment. We have specialty clinics across our medical campus, which is anchored by our 1,200 bed ...
The J&J immunology pipeline already has the antibody drug candidate JNJ-4703, which is in mid-stage clinical development for atopic dermatitis and rheumatoid arthritis.
• Troy Randall – Med – Clinical Immunology and Rheumatology - The epigenetic modifier Kmt2a regulates humoral responses to influenza by orchestrating B cell function in the pre-inducible ...
Maria Shtessel, MD, is an assistant professor of medicine, division of clinical immunology at Mount Sinai. These are the best ways to treat your allergies, depending on your symptoms and severity.
Scipher Medicine, a leader in precision immunology, today announced the public launch of ClinicalTrialRank.com, an innovative ...
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress ...
Stifel 2025 Virtual Immunology & Inflammation Forum – Presentation on Monday, September 15, 2025 at 9:30 a.m. ET ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six scientific abstracts at the European Academy of Allergy and Clinical Immu ...
Dr. William Lumry, M.D., Clinical Professor of Internal Medicine at the University of Texas Health Science Center at Dallas, will present data from the Phase 1b/2 trial of navenibart in a ...